FMC Solano County is a medicare approved dialysis facility center in Dixon, California and it has 12 dialysis stations. It is located in Solano county at 125 North Lincoln Street, Suite B, Dixon, CA, 95620. You can reach out to the office of FMC Solano County at (707) 678-6433. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. FMC Solano County has the following ownership type - Profit. It was first certified by medicare in November, 2006. The medicare id for this facility is 552570 and it accepts patients under medicare ESRD program.
| Name | FMC Solano County |
|---|---|
| Location | 125 North Lincoln Street, Suite B, Dixon, California |
| No. of Dialysis Stations | 12 |
| Medicare ID | 552570 |
| Managed By | Independent |
| Ownership Type | Profit |
| Late Shifts | No |
| 125 North Lincoln Street, Suite B, Dixon, California, 95620 | |
| (707) 678-6433 | |
News Archive
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Shortly after the COVID-19 pandemic first broke out in Wuhan, China, in January, government-issued lockdowns and business restrictions were implemented across the country, affecting more than 1.2 billion people and all types of businesses.
Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), with all patients completing the treatment for hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa achieving an effective clearance of pneumonia as well as a 100% survival rate.
Hospitalization for underage drinking is common in the United States, and it comes with a price tag — the estimated total cost for these hospitalizations is about $755 million per year, a Mayo Clinic study has found. Researchers also found geographic and demographic differences in the incidence of alcohol-related hospital admissions.
› Verified 1 days ago
| NPI Number | 1578921151 |
| Organization Name | Fresenius Medical Care Solano County |
| Doing Business As | Fresenius Medical Care Solano County, Llc |
| Address | 125 N Lincoln St Dixon, California, 95620 |
| Phone Number | (707) 678-6433 |
News Archive
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Shortly after the COVID-19 pandemic first broke out in Wuhan, China, in January, government-issued lockdowns and business restrictions were implemented across the country, affecting more than 1.2 billion people and all types of businesses.
Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), with all patients completing the treatment for hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa achieving an effective clearance of pneumonia as well as a 100% survival rate.
Hospitalization for underage drinking is common in the United States, and it comes with a price tag — the estimated total cost for these hospitalizations is about $755 million per year, a Mayo Clinic study has found. Researchers also found geographic and demographic differences in the incidence of alcohol-related hospital admissions.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 17 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 12 |
News Archive
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Shortly after the COVID-19 pandemic first broke out in Wuhan, China, in January, government-issued lockdowns and business restrictions were implemented across the country, affecting more than 1.2 billion people and all types of businesses.
Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), with all patients completing the treatment for hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa achieving an effective clearance of pneumonia as well as a 100% survival rate.
Hospitalization for underage drinking is common in the United States, and it comes with a price tag — the estimated total cost for these hospitalizations is about $755 million per year, a Mayo Clinic study has found. Researchers also found geographic and demographic differences in the incidence of alcohol-related hospital admissions.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 46 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 324 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Shortly after the COVID-19 pandemic first broke out in Wuhan, China, in January, government-issued lockdowns and business restrictions were implemented across the country, affecting more than 1.2 billion people and all types of businesses.
Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), with all patients completing the treatment for hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa achieving an effective clearance of pneumonia as well as a 100% survival rate.
Hospitalization for underage drinking is common in the United States, and it comes with a price tag — the estimated total cost for these hospitalizations is about $755 million per year, a Mayo Clinic study has found. Researchers also found geographic and demographic differences in the incidence of alcohol-related hospital admissions.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Solano County with elevated calcium levels.
| Patients with hypercalcemia | 46 |
| Hypercalcemia patient months | 324 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 50 |
| Patients with Serumphosphor less than 3.5 mg/dL | 5 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 32 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 31 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 15 |
| Patients with Serumphosphor greater than 7 mg/dL | 17 |
News Archive
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Shortly after the COVID-19 pandemic first broke out in Wuhan, China, in January, government-issued lockdowns and business restrictions were implemented across the country, affecting more than 1.2 billion people and all types of businesses.
Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), with all patients completing the treatment for hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa achieving an effective clearance of pneumonia as well as a 100% survival rate.
Hospitalization for underage drinking is common in the United States, and it comes with a price tag — the estimated total cost for these hospitalizations is about $755 million per year, a Mayo Clinic study has found. Researchers also found geographic and demographic differences in the incidence of alcohol-related hospital admissions.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 33 |
| Patient months included in arterial venous fistula and catheter summaries | 194 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 86 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 3 |
News Archive
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Shortly after the COVID-19 pandemic first broke out in Wuhan, China, in January, government-issued lockdowns and business restrictions were implemented across the country, affecting more than 1.2 billion people and all types of businesses.
Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), with all patients completing the treatment for hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa achieving an effective clearance of pneumonia as well as a 100% survival rate.
Hospitalization for underage drinking is common in the United States, and it comes with a price tag — the estimated total cost for these hospitalizations is about $755 million per year, a Mayo Clinic study has found. Researchers also found geographic and demographic differences in the incidence of alcohol-related hospital admissions.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 29 |
| Hospitalization Rate in facility | 212.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 483.2 |
| Hospitalization Rate: Lower Confidence Limit | 99.9 |
News Archive
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Shortly after the COVID-19 pandemic first broke out in Wuhan, China, in January, government-issued lockdowns and business restrictions were implemented across the country, affecting more than 1.2 billion people and all types of businesses.
Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), with all patients completing the treatment for hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa achieving an effective clearance of pneumonia as well as a 100% survival rate.
Hospitalization for underage drinking is common in the United States, and it comes with a price tag — the estimated total cost for these hospitalizations is about $755 million per year, a Mayo Clinic study has found. Researchers also found geographic and demographic differences in the incidence of alcohol-related hospital admissions.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC Solano County were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 29.8 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 47.6 |
| Readmission Rate: Lower Confidence Limit | 16.2 |
News Archive
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Shortly after the COVID-19 pandemic first broke out in Wuhan, China, in January, government-issued lockdowns and business restrictions were implemented across the country, affecting more than 1.2 billion people and all types of businesses.
Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), with all patients completing the treatment for hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa achieving an effective clearance of pneumonia as well as a 100% survival rate.
Hospitalization for underage drinking is common in the United States, and it comes with a price tag — the estimated total cost for these hospitalizations is about $755 million per year, a Mayo Clinic study has found. Researchers also found geographic and demographic differences in the incidence of alcohol-related hospital admissions.
› Verified 1 days ago